- 17 June
-
From May 20 to 22, the first Eurasian International Medical Forum was held in Ekaterinburg. The event was dedicated to the 80th anniversary of Victory in the Great Patriotic War. The Forum brought together over 1,000 participants and 250 experts from Russia, India, China and Belarus. Medsintez Plant took an active part in scientific program of the Forum and demonstrated its latest developments in the field of import-substituting drugs.
- 13 June
-
The X (XXXI) National Diabetes Congress with international participation was held in Moscow from May 27 to 30, 2025. The event was dedicated to the topic «Diabetes mellitus – a non-infectious pandemic of the 21st century. Macro- and microvascular complications. Issues of interdisciplinary interaction». The Congress was dedicated to the 100th anniversary of the Russian Association of Endocrinologists, the Endocrinology Service of the Russian Federation and the Research Center for Endocrinology.
- 10 June
-
In May 2025, pharmaceutical plant Medsintez Plant LLC joined the leading enterprises that were awarded the status of National Champion based on the results of a comprehensive expert selection. Getting the status of National Champion is a significant event for Medsintez Plant, which emphasizes its contribution to the development of the pharmaceutical industry and strengthening the drug safety of Russia.
- 25 April
-
From April 15 to 18, Ekaterinburg hosted the 6th international specialized exhibition and forum Healthcare of the Urals–2025. This year, 130 companies from 34 cities of Russia and the Republic of Belarus took part in the event, presenting over 1000 units of medical equipment and goods. The residents of the Ural Biomedical Cluster were traditionally among the participants, as well as its collective member – the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region.
- Home
- Cluster members
- URAL NANOTECHNOLOGY CENTER, LLC
URAL NANOTECHNOLOGY CENTER, LLC
URAL NANOTECHNOLOGY CENTER, LLC is a developer and manufacturer of unique innovative products under DEZITOL trademark.
The main activity of the company is production of high quality products based on unique innovative solutions for the Russian and international markets. DEZITOL products are designed to protect against transmission and development of infections, and are successfully used in various areas with higher sanitary requirements, such as medicine and agriculture, and others. Currently, DEZITOL product line includes
Disinfectant (skin antiseptic) DEZITOL A
Skin antiseptic based on isopropyl alcohol for hand treatment, including hands of surgeons, operating field, injection field, gloves on the hands of medical personnel (in accordance with the instructions for use). Having high antimicrobial activity, it is gentle for skin. Effective against pathogens of healthcare-associated infections and Mycobacterium tuberculosis (tested on Mycobacterium terrae).
Passed tests at Disinfectology Research Institute of the Federal Service for the Oversight of Consumer Protection and Welfare.
Effective against pathogens of healthcare-associated infections and Mycobacterium tuberculosis (tested on Mycobacterium terrae).
It is intended for hygienic treatment of hands of personnel at industrial enterprises, catering facilities, municipal facilities, sanitary inspection checkpoints, hairdressing salons, beauty salons, etc.
In accordance with the letter of the Federal Budgetary Institution of Science Disinfectology Research Institute of the Federal Service for the Oversight of Consumer Protection and Welfare ref. No. 77-53-02/468-2020.1.15 dated April 23, 2020, formula of the skin antiseptic DEZITOL A allows application thereof to prevent coronavirus COVID-19 and other viral infections.
Antimicrobial preventive coating DEZITOL B
Innovative product for long- term antimicrobial skin protection. The use thereof in surgical hospitals allows for multi- barrier protection of a patient against pathogenic microflora during operative time and postoperative periods.
DEZITOL B is used on operative field to create a protective incise drape, as well as to close the postoperative wound, to increase comfort of the patient's stay in the hospital due to a possibility of non- dressing treatment of the postoperative wound.
Also, this product is actively used by the population in everyday life as a «Liquid bandage» to close small scratches, small superficial and postoperative wounds, preventing bedsores up to the stage II, protecting the skin around fistulas and stoma.
Protective coating DEZITOL C
A unique development of the Urals scientists — a coating with no analogues in the world. Designed to create a protective coating on surrounding surfaces with a long-lasting antimicrobial effect (up to 12 months).
All products have passed the required tests and are registered. Protective coating DEZITOL C successfully confirmed the declared characteristics in independent accredited laboratories of the European Union countries and the Arab Republic of Egypt.
Currently, the manufactured products have successfully passed long-term full-scale tests and are actively used in medical institutions of the Russian Federation.
Production technology of DEZITOL products is fully automated and complies with GOST ISO 13485-2017 “International Standard. Medical products. Quality management systems. Requirements for Regulatory Purposes” and ISO 9001:2015 “Quality Management Systems. Requirements".
Tel. 8-800-775-52-55 (within Russia calls are free)
E-mail: info@dezitall.ru
